Related to Parthenogenetic Stem Cells Focus of ISCO/ACT IP Deal Extension

• Shrink and EV Group Partner to Develop and Manufacture Nanotech StemDisc Products
  
• ACT Secures $25M and FDA Approval to Start Clinical Trials of ESC-Derived Therapy
  
• Thomson Reuters and ChemAxon Couple Offerings to Search and Visualize Chemical Patents
  
• Scientists Generate Alzheimer-Relevant Neurons from hESCs and iPSCs
  
• BioTime and XenneX Establish LifeMap to Generate Database of Stem Cell Lineages
  
• Ectycell and Caisse des Depots Pledge €12M for Development of Industrial iPSC Platform
  
• Pfizer’s Neusentis Partners with Cellzome on Stem Cell Epigenetics Research
  
• Roslin Cells and Sistemic to Develop miRNA-Based Tools for Monitoring Stem Cell Integrity
  
• Terumo to Buy Cellular Therapies Firm Harvest Technologies for $70M
  
• Supreme Court Rules Against Stanford in Patent Dispute with Roche over HIV Test
  
• CIRM Considers Committing $30M to Augment Stem Cell Research
  
• Molecular Devices Takes Over Genetix’ Drug Discovery Unit
  
• Research Team Allies with ImageIQ to Improve Umbilical Cord Blood Stem Cell Characterization
  
• Scientists Claim Leukemia Stem Cell Signature Independently Predicts Poor Survival in AML
  
• ACT Gets U.K. Go-Ahead to Start First Ever Non-U.S. Trial with hESC-Derived Cell Therapy
  
• European Court Bans Patents Based on Embryo Destruction
  
• California Institute for Reg Med Agrees to Dole Out $30M to Foster Alliances with Industry
  
• Stem Cells that Rebuild Alveoli After Acute Respiratory Distress Syndrome Identified
  
• Two-to-One Majority Differs with European Court Ruling Against Patenting hESCs
  
• Even Split on Whether Federal Circuit Will Change Akamai, McKesson Decisions